- Open Access
Concentrations of nicotine, nitrosamines, and humectants in legal and illegal cigarettes in Mexico
© The Author(s). 2018
- Received: 17 May 2018
- Accepted: 24 September 2018
- Published: 3 October 2018
Article 10 of the World Health Organization Framework Convention on Tobacco Control states the need for industry disclosure of tobacco contents and emissions. Currently, the profiles of key tobacco compounds in legal and illegal cigarettes are largely unknown. We aimed to analyze and compare concentrations of nicotine, nitrosamines, and humectants in legal and illegal cigarettes collected from a representative sample of smokers.
Participants of the International Tobacco Control cohort provided a cigarette pack of the brand they smoked during the 2014 wave. Brands were classified as legal or illegal according to the Mexican legislation. Nicotine, nitrosamines, glycerol, propylene glycol, and pH were quantified in seven randomly selected packs of each brand. All analyses were done blinded to legality status. Average concentrations per brand and global averages for legal and illegal brands were calculated. Comparisons between legal and illegal brands were conducted using t tests.
Participants provided 76 different brands, from which 6.8% were illegal. Legal brands had higher nicotine (15.05 ± 1.89 mg/g vs 12.09 ± 2.69 mg/g; p < 0001), glycerol (12.98 ± 8.03 vs 2.93 ± 1.96 mg/g; p < 0.001), and N-nitrosanatabine (NAT) (1087.5 ± 127.0 vs 738.5 ± 338 ng/g; p = 0.006) concentrations compared to illegal brands. For all other compounds, legal and illegal brands had similar concentrations.
Compared to illegal cigarettes, legal brands seem to have higher concentrations of nicotine, NAT, and glycerol. Efforts must be made to implement and enforce Article 10 of the Framework Convention on Tobacco Control to provide transparent information to consumers, regulators, and policy-makers; and to limit cigarette engineering from the tobacco industry.
- Nicotine or derivatives
- Tobacco constituents
Articles 9 and 10 of the World Health Organization Framework Convention on Tobacco Control (WHO-FCTC) state that all countries must take action to ensure industry disclosure of tobacco contents and emissions as well as their regulation.  The minimal standards for reporting depend on the capacity of each country to measure tobacco compounds and emissions . In 2016, the WHO-FCTC progress report found that of all the countries involved 67% are disclosing information on contents and 62% on emissions, while 54% regulate contents, and 50% emissions . In the vast majority of countries, reports on tobacco products contents are limited to compounds defined in 1971 by the US Federal Trade Commission: nicotine and tar .
Monitoring of tobacco contents in cigarettes has been infrequent . Nicotine [5, 6] and tobacco-specific nitrosamines across countries and cigarette brands have been measured, finding important differences even within the same brand [7–9]. Studies across countries have focused on one international brand (largely Marlboro Red) or on a single local brand per country. All previous studies have been restricted to legal brands, and to date, no study has reported these components in illegal cigarettes. Illegal products can represent up to 10% of the market , and the variability of sources for illegal tobacco could imply larger health risks, given that no standards of production are imposed .
On this paper, we aimed to analyze and compare a group of tobacco compounds that have been listed by the WHO as potential targets for regulation under Article 10 of the WHO-FCTC including legal and illegal brands from Mexico , collected from a representative sample of smokers. We focused in nicotine, the main addictive component and the four nitrosamines found in tobacco (N-nitrosoanabasine (NAB), 4-(methylnistrosamino)-1-(3-pyridyl)-1-butanone (NNK), N-nitrosonornicotine (NNN), and N-nitrosoanatabine (NAT)), considered to be the most carcinogenic tobacco constituents . We also measured pH, which has been shown to be manipulated by the addition of compounds such as ammonia to increase the uptake of nicotine,  and two humectants (glycerol and propylene glycol), substances that have been known to be added or modified by the industry to improve the smoking experience . Given their lack of regulation, we expected all of these compounds to be higher in illegal brands.
The International Tobacco Control Policy Evaluation Project (ITC Project) involves ongoing data collection from population-based cohorts of smokers in more than 25 countries in order to evaluate the key policies of the WHO-FCTC. The Mexican administration of the ITC (ITC Mexico) started in 2006 and has so far collected seven waves of data from representative sample of smokers in the following cities: Mexico City, Guadalajara, Tijuana, Monterrey, Puebla, and Leon, with approximately 280 participants per city each wave, with a larger sample in Mexico City, which is significantly larger than the other cities. The ITC Project methods have been previously described elsewhere .
For this study, data were collected in 2014 from ITC participants in Mexico City, Guadalajara, and Monterrey, the three largest cities in Mexico. These cities were selected based on their variability of cigarette brands , participation rates (80–90%) and their population density. Participants were asked to provide a new pack of their current cigarette brand at the time of the survey. A sample of 600 cigarette packs was estimated to be enough to have a minimum of 17 packs of the most common cigarette brands in Mexico [18–20]. This sample size allowed us to detect a significant difference between common cigarette brands in nicotine concentration of 3 ng/g with an alpha of 0.05 and an 80% power. Based on data for smokers’ preferred brands in prior surveys, we expected that this sample size would provide 150 packs of less common cigarette brands. The packs were identified with the survey id number of the participant in order to match the pack information with the subject’s survey data.
By law, legal cigarette brands must be registered in the Federal Official Gazette of Mexico. To classify cigarette brands as legal, we first reviewed if brands were registered in the Federal Official Gazette of Mexico on 2014. In addition, Mexican law requires cigarette packs to have a set of 4 pictograms occupying 30% of the front, warning labels on the side, a health message occupying 100% of the back side of the pack changing through the year, and the legend “to be sold exclusively in Mexico” . Some cigarette packs of registered brands could have been legally produced in another country but smuggled into Mexico; to identify these cases, we further scrutinized pictograms and warning labels, to make sure they complied with the current Mexican legislation, and reviewed COFEPRIS warnings on illegal cigarettes and the lists containing illegal brand names . If a pack complied with the law, it was classified as legal; otherwise, they were classified as illegal.
Quantitation of compounds
We received 770 packs from the ITC participants. Seven packs of each brand were randomly selected and submitted to the analysis of nicotine and humectants; in some cases, (9 legal and 13 illegal brands) less than seven packs were available, in such cases, we only analyzed the available packs (Additional file 1). In the case of nitrosamines, seven packs of the 10 most common legal and illegal brands were tested. We then estimated average concentrations for each brand and estimated the global average for legal and illegal brands using the average concentrations for each brand. All analyses were done blinded to the brand and legality status of the pack, and all the compounds, except for nitrosamines, were analyzed the Analytic Tobacco Compound Laboratory at The National Institute of Public Health of Mexico.
Nitrosamines (TSNAs) quantification was done by a private laboratory in NC, USA . TSNAs were extracted from tobacco using an aqueous solution of ammonium acetate and shaken mechanically. Tobacco extracts were subsequently filtered and analyzed by liquid chromatography-mass spectrometry. The level of each TSNA present in a tobacco sample was quantified using one of two internal standards (d4-NNK and d4-NNN). D4-NNN was used to correct NNN, and d4-NNK was used to correct the other three TSNAs.
The process for nicotine quantitation followed the methods described by Coresta . Briefly, after conditioning tobacco, nicotine was extracted with a mixture of n-hexane, sodium hydroxide solution, and water. The organic layer was analyzed by gas chromatography with a FID detector. The detection limit was 0.08 mg/g, and the quantitation limit was 0.25 mg/g.
Glycerol and propylene glycol quantitation was performed according to AOAC International procedures . Briefly, humectants were extracted from tobacco with a methanol solution. The extract was then analyzed with a spectrometer detector. The detection limits for glycerol and propylene glycol were 0.11 and 1.14 mg/g, respectively, and the quantitation limits were 0.17 and 1.57 mg/g respectively.
For pH quantitation, deionized water was added to tobacco, after shaking it and letting it rest in the dark for 45 min, we decanted the supernatant and measured pH using a pH electrode with and internal reference of Ag/AgCl, previously calibrated with buffers of 4, 7, and 10 pH levels.
We provide prevalence and 95% confidence intervals for the most commonly smoked brands considering the complex survey design. Descriptive statistics were calculated for each cigarette brand. Mean and standard deviations of each tobacco compound for legal and illegal brands were calculated. We computed t tests to compare the mean level of each compound between legal and illegal brands. A 0.05 significance level was defined for all tests. All analyses were performed using Stata 13.1 (College Station, TX, USA: StataCorp LP). R version 2.3.4 (The R Foundation for Statistical Computing Platform: x86_64-apple-darwin13.4.0 (64-bit)) was used to plot all graphs.
Most common cigarette brand distribution and manufacturer by legal status (Mexico 2014)
Legal brands (manufacturera)
Marlboro Red (PMI)
28.8 [22.6, 35.8]
13.9 [8.8, 21.2]
Montana Shots (BAT
12.7 [8.9, 17.7]
9.5 [6.6, 13.4]
Marlboro Gold (PMI)
6.3 [4.4, 8.9]
Pall Mall Green Click-on (BTA)
5.1 [2.8, 9.4]
Benson & Hedges Menthol (PMI)
4.2 [2.4, 7.1]
Lucky Strike Red (BTA)
2.5 [1.2, 5.1]
Delicados Oval (PMI)
1.7 [0.7, 3.9]
Benson & Hedges Gold (PMI)
1.6 [0.9, 2.8]
Marlboro Fresh (PMI)
1.5 [0.7, 3.1]
Delicados Light (PMI)
1.4 [0.4, 4.3]
Marlboro Ice Xpress (PMI)
1.3 [0.5, 3.4]
1.3 [0.6, 2.8]
Pall Mall White Click-on (BAT
1.2 [0.6, 2.4]
Lucky Strike Additive Free (BAT)
1.0 [0.5, 2.0]
Pall Mall Red (BAT)
0.9 [0.4, 2.0]
Pall Mall Ex White (BAT)
0.8 [0.3, 2.0]
Pall Mall Fresh Click-on (BAT)
0.7 [0.3, 1.5]
Pall Mall Red Click-on (BAT)
0.6 [0.1, 3.7]
We aimed to determine the concentrations of nicotine, pH, nitrosamines, and humectants in a representative sample of legal and illegal cigarette brands smoked in Mexico. We found that 6.8% of smokers living in the three largest metropolitan areas of Mexico provided illegal cigarette packs. Legal brands had higher concentrations of nicotine, glycerol, and NAT compared to illegal brands. Other nitrosamines, propylene glycol, and pH were similar between legal and illegal brands.
Nicotine is the primary addictive compound in cigarettes, while its health risks are not as high as other compounds, it is key to develop and sustain addiction . We found that legal cigarette brands had a mean nicotine concentration of 15 mg/g, compared to 12 mg/g in illegal brands. Nicotine concentrations in Mexican cigarettes were studied previously in 2002 . At that time, the dominant Marlboro Red cigarettes had 21 mg/g nicotine, and levels in the nationally produced brand Boots were lower (16 mg/g). In 1994 Benowitz, et al.  proposed gradually reducing nicotine levels over the course of 10–15 years to achieve a concentration of 0.17 mg of nicotine per cigarette to avoid reaching a daily dose of more than 5 mg of nicotine. Experimental studies show that slowly decreasing nicotine content in cigarettes is accompanied by a slow decrease in nicotine levels by smokers and a progressive decline in nicotine intake [28–31]. Based on our analyses, legal cigarettes in Mexico currently have 9–11 mg/cigarette, while illegal brands have 7–9 mg/cigarette, so currently, cigarette brands are 2 and 1.7 times above the recommended daily limit. Despite recent studies supporting Benowitz’s initial proposal , challenges for low-nicotine cigarettes prevail, mainly the opposition of tobacco companies . The systematic analysis of nicotine in cigarettes provides transparency as to the addictive potential of cigarettes, making it urgent for Article 10 of the WHO-FCTC to be implemented.
Nitrosamines are one of the main carcinogenic compounds of tobacco . We found that NAT concentrations were higher for legal compared to illegal brands, although levels for other nitrosamines were similar between legal and illegal cigarettes. A previous study of NNN and NNK levels in Mexican cigarettes found that the Marlboro Red brand cigarettes had a mean of 1.0 ìg/g of NNK + NNN levels . We found that among legal brands, the levels of NNK + NNN were 1.5 ì g/g, while the concentration was 1.6g/g for illegal brands. Because nitrosamines are formed during tobacco processing, regulation of tobacco processing would likely reduce the amount of nitrosamines found in cigarettes. Several calls have been made to modify production standards to reduce nitrosamine contents. While this proposal is controversial , we consider that nitrosamines should be regularly measured as part of the regulatory tasks of health agencies across the world to better inform consumers about the health risks of smoking.
Additives such as humectants play an important role in smoking initiation and addiction by making the smoking experience more pleasant one . We found that while propylene glycol levels were similar, legal brands had a glycerol concentration of 13 mg/g compared to that of 3 mg/g in illegal brands. Glycerol is used to increase shelf life and to improve the palatability of cigarettes [36, 37]. Cigarettes with additives are usually more appealing to smokers, since they enhance flavor and provide a smoother smoking experience; in addition, some additives mask the odor of sidestream smoke . The harmful effects of humectants and added flavors are yet to be described. Recent evidence from e-cigarette research shows that flavors may affect nicotine absorption by modifying pH; in addition, they increase nicotine exposure though flavor liking [39, 40]. The regulation of flavors and humectants is also recommended by Article 9 of the WHO-FCTC1, and it might have an additional impact on the appeal and palatability of cigarettes for youth, as well as for promoting cigarette addiction.
Given their lack of regulation, we expected to observe higher concentrations of nicotine, nitrosamines, and humectants in illegal cigarettes. However, our results suggest that legal brands have higher concentrations of nicotine, NAT and glycerol, and comparable concentrations to illegal brands for all other compounds. We could not find previous references to explain this pattern, although we hypothesize that it could be linked to the role that legal and illegal cigarettes play in the market. Previous research has shown that illegal cigarette purchases tend to be unplanned and depend on availability and price [41, 42], and could respond to tax avoidance . In contrast, legal brands have been known to engineer their products, including chemical composition, to ensure they attract and sustain their market share through standardized product characteristics, such as flavor and smoking experience.38 Nicotine and humectants have been referred to in legacy documents of the tobacco industry as components that could produce competitive advantage [37, 44]. Therefore, observed differences in these compounds could respond to engineering efforts aimed at sustaining the market share of legal brands in Mexico. An alternative explanation of differences could be confounding by type of cigarette. Regular and flavored cigarettes were found in both legal and illegal brands, but we only found light cigarettes in legal brands (Additional file 3). Since compound concentrations could differ by type of cigarette, we restricted compound comparisons between legal and illegal brands to regular cigarettes (75% of all packs). Within regular cigarettes, legal brands still had higher nicotine, glycerol, and NAT than illegal brands (Additional file 4).
Our study has some limitations worth mentioning. Our analyses were restricted to raw tobacco, with no evaluation of emissions, which limits the comparability of our results to an important proportion of the literature. Still, measuring compounds in raw tobacco is frequent, and studies measuring nicotine and nitrosamine using similar techniques have found comparable concentration levels [5, 45]. Also, current regulatory efforts are focusing in the concentration of nicotine in tobacco filler rather than in emissions, making our measurements relevant within a regulatory context [46, 47]. The eight components measured are far from a complete list of relevant constituents, and as such, these results should not be interpreted as a proof for illegal cigarettes to be safer, healthier, or better than legal ones; many other compounds could be present in higher concentrations in illegal cigarettes, including pesticides and metals [48, 49]. Indeed, prior research found that Mexican cigarettes had higher levels of arsenic than in other countries . Still, we believe that measuring nicotine, nitrosamines, and humectants is an informative first step towards the implementation of Articles 9 and 10 of the WHO-FCTC. Lastly, by design, our sample of cigarette packs was obtained from a representative sample of smokers, and as such, it does not provide a complete list of all brands of cigarettes available in Mexico; our aim was to capture the characteristics of brands that are frequently used in the country, rather than producing a comprehensive characterization of all brands. Such task may be needed once regulatory agencies start evaluating compliance with product regulation, but it is beyond the scope of our paper.
Our results highlight the importance of developing better regulatory efforts and to implement controls for both legal and illegal tobacco. We found that nicotine, nitrosamines, and humectant concentrations are highly variable across legal brands, and in average appear to be higher than those observed in illegal cigarettes. Regulatory standards proposed in Article 9 of the FCTC to reduce the attractiveness, addictiveness, and toxicity of cigarettes through compound regulation could change this landscape if legal cigarettes are held to a maximum level of key compounds. Illegal cigarettes, however, will circumvent these regulations, requiring regulatory efforts to reduce the black market for cigarettes. Nicotine content regulation is currently being discussed by the FDA, in an effort to decrease cigarette addictiveness . In our study, the lack of a regulatory framework allowed legal brands to have twice the nicotine concentration needed for addiction. Steps towards tobacco regulation and disclosure have been taken by the EU and the USA , and the WHO is developing guidelines to implement Articles 9 and 10 . Establishing maximum permissible concentrations of key compounds and maintaining a strong, periodical, and independent monitoring system to assess compliance and provide public disclosure of tobacco contents and emissions will be needed to effectively implement Articles 9 and 10 of the FCTC.
More than 48 billion cigarettes are sold in Mexico every year, yet, they are largely unregulated in terms of their contents and little is known about specific constituents . In agreement with the WHO-FCTC, current legislation in Mexico enforces public smoking bans, requires warning labels in all cigarette packs, and bans all promotional advertising of cigarettes . The General Law for Tobacco Control requires from tobacco companies to provide reports of tobacco constituents, but no independent assessment of the accuracy of those reports are conducted. As we move towards implementation of Article 10, it will be important to increase the capabilities of countries to conduct independent assessments of tobacco compounds and to establish funding strategies to maintain a surveillance system of tobacco constituents and emissions. Independent assessment will be key to eliminate interference from the industry.
Additional support for data collection was provided through Geoffrey T. Fong from a Senior Investigator Award from the Ontario Institute for Cancer Research and a Prevention Scientist Award from the Canadian Cancer Society Research Institute, grant number MOP 115016.
We would like to thank Abigail Flores-Escartin, Maria de la Luz Soriano-Martínez, and Jose Juan Mares Samano for their work analyzing the cigarette packs.
This work was supported by the National Council of Science and Technology (CONACYT) grant number SALUD-2013-1-202671.
Availability of data and materials
The datasets generated and/or analyzed during the current study are not publicly available to ensure the privacy and confidentiality of the participants.
TBG and JFT conceptualized and designed the study, provided critical comments during the manuscript preparation process, and approved the final manuscript as submitted. ABB carried out the analysis, drafted the initial manuscript, critically reviewed and revised the manuscript, and approved the final manuscript as submitted. MHA and LMRS edited the early version of the manuscript, critically reviewed and revised the manuscript, and approved the final manuscript as submitted.
Ethics approval and consent to participate
This study was approved by the Ethics Review Board of the National Institute of Public Health of Mexico. All the participants provided written consent to participate in the International Tobacco Control Policy Evaluation Project.
Consent for publication
No data from participants is being published in this study.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- World Health Organization (WHO). WHO Framework Convention on Tobacco Control. WHO Press. 2005;1(3):270–1. https://doi.org/10.1016/j.precon.2005.12.001.View ArticleGoogle Scholar
- World Health Organization (WHO). Global Progress Report of the Implementation of the WHO Framework Convention on Tobacco Control.; 2016. Document FCTC/COP7/15 at http://www.who.int/fctc/cop/cop7/FCTC_COP_7_15_EN.pdf?ua=1.Google Scholar
- Davis RM, Healy P, Hawk SA. Information on tar and nicotine yields on cigarette packages. Am J Public Health. 1990;80(5):551–3.View ArticleGoogle Scholar
- Wu W, Ashley DL, Watson CH. Determination of nicotine and other minor alkaloids in international cigarettes by solid-phase microextraction and gas chromatography/mass spectrometry. Anal Chem. 2002;74(19):4878–84. https://doi.org/10.1021/ac020291p.View ArticlePubMedGoogle Scholar
- Henningfield J, Fant R, Radzius A, Frost S. Nicotine concentration, smoke pH and whole tobacco aqueous pH of some cigar brands and types popular in the United States. Nicotine Tob Res. 1999;1(2):163–8. https://doi.org/10.1080/14622299050011271.View ArticlePubMedGoogle Scholar
- Fischer S, Castonguay A, Kaiserman M, Spiegelhalder B, Preussmann R. Tobacco-specific nitrosamines in Canadian cigarettes. J Cancer Res Clin Oncol. 1990;116(6):563–8. https://doi.org/10.1007/BF01637075.View ArticlePubMedGoogle Scholar
- Spiegelhalder B, Bartsch H. Tobacco-specific nitrosamines. Eur J Cancer Prev. 1996;5(Supplement I):33–8 http://www.ncbi.nlm.nih.gov/pubmed/8972290.View ArticleGoogle Scholar
- Stepanov I, Knezevich A, Zhang L, Watson C, Hatsukami D, Hecht S. Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob Control. 2012;21(1):44–8. https://doi.org/10.1136/tc.2010.042192.View ArticlePubMedGoogle Scholar
- World Health Organization (WHO), WHO Framework Convention on Tobacco Control (FCTC). Illegal Trade of Tobacco Products: What Youd Should Know to Stop It.; 2015.Google Scholar
- Joossens L, Raw M. From cigarette smuggling to illicit tobacco trade. Tob Control. 2012;21(2):230–4. https://doi.org/10.1136/tobaccocontrol-2011-050205.View ArticlePubMedGoogle Scholar
- World Health Organization (WHO) study group on tobacco product regualtion. Report on the Scientific Basis of Tobacco Product Regulation: Fifth Report of a WHO Study Group.; 2015. apps.who.int/iris/bitstream/10665/161512/1/9789241209892.pdf.
- Baker RR, Pereira Da Silva JR. Smith G. The effect of tobacco ingredients on smoke chemistry. Part II: casing ingredients. Food Chem Toxicol. 2004;42S:S3–S37. https://doi.org/10.1016/j.fct.2003.08.009.View ArticleGoogle Scholar
- International Tobacco Control Policy Evaluation Project. ITC Project. 2011 http://www.itcproject.org/. Accessed 20 June 2011.Google Scholar
- Institute for Global Tobacco Control. TPackSS: Tobacco pack surveillance system. 2014 http://globaltobaccocontrol.org/tpackss/pack-search/. Accessed 1 Nov 2016.Google Scholar
- Reynales-Shigematsu LM, Thrasher JF, Lazcano-Ponce E, Hernández-Ávila M. Salud Pública Y Tabaquismo Volumen I. In: Políticas Para El Control Del Tabaco En México; 2013. https://www.insp.mx/images/stories/Produccion/pdf/130206_reporteTabacoVol1.pdf.Google Scholar
- Organización Panamericana de la Salud (OPS); Instituto Nacional de Salud Pública (INSP). Encuesta Global de Tabaquismo En Adultos. México 2009; 2010. https://doi.org/10.1007/s13398-014-0173-7.2.View ArticleGoogle Scholar
- Sáenz de Miera Juárez B, Thrasher JF, Reynales Shigematsu LM, Hernández Ávila M, Chaloupka FJ. Tax, price and cigarette brand preferences: a longitudinal study of adult smokers from the ITC Mexico survey. Tob Control. 2014;23(suppl_1):i80–5. https://doi.org/10.1136/tobaccocontrol-2012-050939.View ArticlePubMedGoogle Scholar
- Diario Oficial de la Federación. Ley General para el Control del Tabaco. In: D Of la Fed; 2014.Google Scholar
- COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios). Alerta Sanitaria: COFEPRIS Alerta Sobre Cigarros Que Son Comercializados de Forma Ilegal.; 2014.Google Scholar
- American Association for Laboratoty Accreditation. Scope of accreditation to ISO/IEC 17025:2005 Enthalpy Analytical, inc. Valid To: September 30, 2017. http://enthalpy.com/wp-content/uploads/2016/06/Durham-A2LA-Accreditation.pdf. Published 2017.Google Scholar
- Coresta. Determination of Nicotine in Tobacco and Tobacco Products by Gas Chromatographic Analysis. 2005.Google Scholar
- AOAC International. AOAC official method 971.02: glycerol, propylene glycol, and Trietheyne glycol in cased cigarette cut filler and ground Tobaco. Gas chromatographic method. Vol 5.; 1998.Google Scholar
- Centers for Disease Control and Prevention (CDC). The health consequences of smoking-50 years of progress: a report of the surgeon general.; 2016.Google Scholar
- Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. N Engl J Med. 1994;331(2):123–5.View ArticleGoogle Scholar
- Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomark Prev. 2007;16(11):2479–85. https://doi.org/10.1158/1055-9965.EPI-07-0393.View ArticleGoogle Scholar
- Benowitz NL, Dains KM, Hall SM, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomark Prev. 2012;21(5):761–9. https://doi.org/10.1158/1055-9965.EPI-11-0644.View ArticleGoogle Scholar
- Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction. 2007;102(2):324–34. https://doi.org/10.1111/j.1360-0443.2006.01670.x.View ArticlePubMedGoogle Scholar
- Rose J, Behm F. Effects of low nicotine content cigarettes on smoke intake. Nicotine Tob Res. 2004;6(2):309–19. https://doi.org/10.1080/14622200410001676378.View ArticlePubMedGoogle Scholar
- Hatsukami DK, Perkins KA, MG LS, et al. Nicotine reduction revisited: science and future directions. Tob Control. 2010;19(5):e1. https://doi.org/10.1136/tc.2009.035584.View ArticlePubMedPubMed CentralGoogle Scholar
- Kozlowski LT. Prospects for a nicotine-reduction strategy in the cigarette endgame: alternative tobacco harm reduction scenarios. Int J Drug Policy. 2015;26(6):543–7. https://doi.org/10.1016/j.drugpo.2015.02.001.View ArticlePubMedGoogle Scholar
- World Health Organization (WHO). The scientific basis of tobacco product regulation. Second report of a WHO study group. In: WHO Tech Rep Ser; 2008.Google Scholar
- Boyle P, Gary N, Henningfield JE. Tobacco: science, policy and public health. In: Oxford University press; 2010.Google Scholar
- Alpert HR, Agaku IT, Connolly GN. A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction. Tob Control. 2016;25(4):444–50. https://doi.org/10.1136/tobaccocontrol-2014-051943.View ArticlePubMedGoogle Scholar
- National Institute for Public Health and the Enviornment (RIVM). Tobacco additives. In: Information for professionals; 2012.Google Scholar
- Rabinoff M, Caskey N, Rissling A, Park C. Pharmacological and chemical effects of cigarette additives. Am J Public Health. 2007;97(11):1981–91. https://doi.org/10.2105/AJPH.2005.078014.View ArticlePubMedPubMed CentralGoogle Scholar
- Mcneill A, Iringe-Koko B, Bains M, Bauld L, Siggens G, Russell A. Countering the demand for, and supply of, illicit tobacco: an assessment of the “north of England tackling illicit tobacco for better health” Programme. Tob Control. 2014;23:e44–50. https://doi.org/10.1136/tobaccocontrol-2013-050957.View ArticlePubMedGoogle Scholar
- Moodie C, Hastings G, Joossens L. Young adult smokers’ perceptions of illicit tobacco and the possible impact of plain packaging on purchase behaviour. Eur J Pub Health. 2012;22(2):251–3. https://doi.org/10.1093/eurpub/ckr038.View ArticleGoogle Scholar
- Velicer C, Lempert LK, Glantz S. Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation. Tob Control. 2014;0:1–12. https://doi.org/10.1136/tobaccocontrol-2014-051571.View ArticleGoogle Scholar
- Ashley DL, Beeson MD, Johnson DR, et al. Tobacco-specific nitrosamines in tobacco from U.S. brand and non-U.S. brand cigarettes. Nicotine Tob Res. 2003;5(3):323–31. https://doi.org/10.1080/1462220031000095311.View ArticlePubMedGoogle Scholar
- He Y, Von-Lampe K, Wood L, Kurti M. Investigation of lead and cadmium in counterfeit cigarettes seized in the United States. Food Chem Toxicol. 2015;81:40–5. https://doi.org/10.1016/j.fct.2015.04.006.View ArticlePubMedGoogle Scholar
- Swami K, Judd CD, Orsini J. Trace metals analysis of legal and counterfeit cigarette tobacco samples using inductively coupled plasma mass spectrometry and cold vapor atomic absorption spectrometry. Spectrosc Lett. 2009;42(8):479–90. https://doi.org/10.1080/00387010903267799.View ArticleGoogle Scholar
- Caruso RV, Fix BV, Thrasher JF, et al. Differences in cigarette design and metal content across five countries: results from the international tobacco control (ITC) project. Tob Regul Sci. 2016;2(2):166–75.View ArticleGoogle Scholar
- U.S. Food and Drug Administration (FDA). Tobacco products: compliance, enforcement & training.Google Scholar
- Waters H, Saenz de Miera B, Ross H, Reynales Shigematsu LM. La Economía Del Tabaco Y Los Impuestos Al Tabaco En México. In: París: Unión Internacional contra la Tuberculosis y Enfermedades Respiratorias; 2010. http://www.who.int/entity/fctc/reporting/party_reports/mexico_annex2_economy_of_tobacco_and_taxes_in_mexico.pdf.Google Scholar